rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2001-5-4
|
pubmed:abstractText |
L-3-[123I]iodo-alpha-methyl-tyrosine (IMT) is a modified amino acid that is avidly taken up by many tumors. Uptake is based on the increased transmembrane transport of amino acids in malignancies. IMT is the only amino acid tracer suitable for SPECT. The aim of this study was to determine the feasibility of IMT SPECT in the detection, staging, and treatment evaluation of non-small cell lung cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0161-5505
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
579-85
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11337545-Adult,
pubmed-meshheading:11337545-Aged,
pubmed-meshheading:11337545-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:11337545-Feasibility Studies,
pubmed-meshheading:11337545-Female,
pubmed-meshheading:11337545-Fluorodeoxyglucose F18,
pubmed-meshheading:11337545-Humans,
pubmed-meshheading:11337545-Lung Neoplasms,
pubmed-meshheading:11337545-Lymphatic Metastasis,
pubmed-meshheading:11337545-Male,
pubmed-meshheading:11337545-Mediastinum,
pubmed-meshheading:11337545-Methyltyrosines,
pubmed-meshheading:11337545-Middle Aged,
pubmed-meshheading:11337545-Radiopharmaceuticals,
pubmed-meshheading:11337545-Sensitivity and Specificity,
pubmed-meshheading:11337545-Tomography, Emission-Computed,
pubmed-meshheading:11337545-Tomography, Emission-Computed, Single-Photon
|
pubmed:year |
2001
|
pubmed:articleTitle |
L-3-[123I]iodo-alpha-methyl-tyrosine SPECT in non-small cell lung cancer: preliminary observations.
|
pubmed:affiliation |
PET Center and Department of Nuclear Medicine, University Hospital Groningen, Groningen, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|